三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
替妥尤单抗III期研究眼CAS值及眼眼球总应答率
替妥尤单抗III期研究眼CAS值及眼眼球总应答率
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:396KB
图片尺寸:1210*1076
同报告图片
/
4
5Lul5LiL5piv5qC55o2u5Zu+54mH5Lit55qE5pWw5o2u55Sf5oiQ55qE6KGo5qC877yaCgp8IOmaj+iuv+WRqOaVsCB8IOabv+WmpeWwpOWNleaKlyBDQVPlgLzkuLow5oiWMeeahOWPl+ivleiAheeZvuWIhuavlCB8IOabv+WmpeWwpOWNleaKlyDmgLvlupTnrZTnjocgfAp8IDotLTogfCA6LS06IHwgOi0tOiB8CnwgMCAgICB8IDAlICAgfCAwJSAgIHwKfCAzICAgIHwgNDQuNCV8IDU5LjMlfAp8IDYgICAgfCAyMy4xJXwgMy43JSB8CnwgOSAgICB8IDgzLjUlfCA4MC4yJXwKfCAxMiAgIHwgMTYuNiV8IDMuNiUgfAoK6LWE5paZ5p2l5rqQ77yaMjAyNOW5tENEU+Wkp+S8mu+8jOa1meWVhuivgeWIuOeglOeptuaJgA==
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
fCDoja/lk4HlkI3np7AgfCDpnbbngrkgfCDkvZznlKjmnLrliLYgfCDnoJTlj5HmnLrmnoQgfCDnlr7nl4UgfCDkuK3lm73pmLbmrrUgfAp8LS0tLS0tLS0tLXwtLS0tLS18LS0tLS0tLS0tLXwtLS0tLS0tLS18LS0tLS0tfC0tLS0tLS0tLS18CnwgSUJJMzg5ICAgfCBDRDM7Q0xETjE4LjIgfCBhbnRpLUNMRE4xOC4yL0NEM+WPjOeJueW8guaAp+aKl+S9kyB8IOS/oei+vueUn+eJqSB8IOiDsOiFuueZjO+8jOWunuS9k+eYpOetiSB8IElJ5pyf5Li05bqKIHwKfCBRTFMzMTkwNSB8IENEMztDTEROMTguMiB8IGFudGktQ0xETjE4LjIvQ0Qz5Y+M54m55byC5oCn5oqX5L2TIHwg6b2Q6bKB5Yi26I2vIHwg5a6e5L2T55ikIHwgSUnmnJ/kuLTluoogfAp8IEFaRDU4NjMgIHwgQ0QzO0NMRE4xOC4yIHwgYW50aS1DTEROMTguMi9DRDPlj4znibnlvILmgKfmipfkvZMgfCBBc3RyYVplbmVjYTvlkozpk4LljLvoja8gfCDog7Dohbrlr7znrqHnmYznrYkgfCBJL0lJ5pyf5Li05bqKIHwKfCBBU1AyMTM4ICB8IENEMztDTEROMTguMiB8IGFudGktQ0xETjE4LjIvQ0Qz5Y+M54m55byC5oCn5oqX5L2TIHwgQXN0ZWxsYXMgUGhhcm1hO1hlbmNvciB8IOiDg+mjn+euoeS6pOeVjOWkhOeZjDvog4PnmYznrYkgfCBJ5pyf5Li05bqKIHwKfCBQTTMwMjMgICB8IENEMztDTEROMTguMiB8IENBUiBU57uG6IOe55aX5rOVO0NBUiBUIGVuZ2FnZXIgfCDmma7nsbPmlq8gfCDlrp7kvZPnmKQgfCBJ5pyf5Li05bqKIHwKfCBMTkYyMDA3ICB8IENEMztDTEROMTguMiB8IGFudGktQ0xETjE4LjIvQ0Qz5Y+M54m55byC5oCn5oqX5L2TIHwg6bKB5Y2X5Yi26I2vIHwg5a6e5L2T55ikO+iDg+eZjCB8IEnmnJ/kuLTluoogfAp8IEFNRyA5MTAgIHwgQ0QzO0NMRE4xOC4yIHwgYW50aS1DRDMvQ0xETjE4LjLlj4znibnlvILmgKfmipfkvZMgfCBBbWdlbjvnmb7mtY7npZ7lt54gfCDog4Ppo5/nrqHkuqTnlYzlpITnmYw76IOD55mMIHwg55Sz5oql5Li05bqKIHwKCui1hOaWmeadpea6kO+8mkluc2lnaHTmlbDmja7lupPvvIjmiKroh7MyMDI15bm0M+aciDI45pel77yJ77yM5rWZ5ZWG6K+B5Yi456CU56m25omA
所属报告:
信达生物-港股公司深度报告:IO+ADC 全球创新领先减重等慢病开花-250427(30页).pdf
打包全文图表
相关数据
全球I-III期临床试验启动数量(2016-2025年)
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
收藏
行业数据
2026-07-02
原图定位
查看详情
图D.附录III.RRF对荷兰的数字溢出效应:按原产国划分的贡献
收藏
行业数据
2026-07-01
原图定位
查看详情
图C.附录III.RRF对德国的数字溢出效应:按原产国划分的贡献
fCDljp/kuqflm70gfCDotKHnjK7nmb7liIbmr5TvvIgl77yJIHwKfC0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS18Cnwg6KW/54+t54mZIHwgMjQuNSAgICAgICAgICAgfAp8IOaEj+Wkp+WIqSB8IDI2LjEgICAgICAgICAgIHwKfCDms5Xlm70gICB8IDkuNyAgICAgICAgICAgIHwKfCDms6LlhbAgICB8IDYuMSAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muWnlOWRmOS8muacjeWKoemDqOmXqOOAgg==
收藏
行业数据
2026-07-01
原图定位
查看详情
度普利尤单抗(达必妥)全球销售额(2017-2025年)
fCDlubTku70gfCDnvo7lm73vvIjnmb7kuIfmrKflhYPvvIkgfCDmrKfmtLLvvIjnmb7kuIfmrKflhYPvvIkgfCDlhbbku5blm73lrrblkozlnLDljLrvvIjnmb7kuIfmrKflhYPvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8IDIwMTcgfCAyMDAgICAgICAgICAgICAgIHwgNTAgICAgICAgICAgICAgICB8IDUwICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMTggfCA4MDAgICAgICAgICAgICAgIHwgMTAwICAgICAgICAgICAgICB8IDEwMCAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMTkgfCAxODAwICAgICAgICAgICAgIHwgMTUwICAgICAgICAgICAgICB8IDE1MCAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjAgfCAyODAwICAgICAgICAgICAgIHwgMjAwICAgICAgICAgICAgICB8IDIwMCAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjEgfCA0MDAwICAgICAgICAgICAgIHwgNTAwICAgICAgICAgICAgICB8IDUwMCAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjIgfCA2NTAwICAgICAgICAgICAgIHwgNzAwICAgICAgICAgICAgICB8IDgwMCAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjMgfCA4MjAwICAgICAgICAgICAgIHwgOTAwICAgICAgICAgICAgICB8IDEyMDAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjQgfCAxMDIwMCAgICAgICAgICAgIHwgMTEwMCAgICAgICAgICAgICB8IDE3MDAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjUgfCAxMTcwMCAgICAgICAgICAgIHwgMTQwMCAgICAgICAgICAgICB8IDI5MDAgICAgICAgICAgICAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya6LWb6K+66I+y5a2j5oql77yM55Sz5LiH5a6P5rqQ56CU56m2
收藏
行业数据
2026-05-28
原图定位
查看详情
全球主要在研CLDN18.2ADC产品(II/III期)
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
收藏
行业数据
2026-05-28
原图定位
查看详情
PCSK9药物研发格局(筛选全球最高研发阶段进入III期的活跃管线)
PHRhYmxlIGJvcmRlcj0iMSIgY2VsbHNwYWNpbmc9IjAiIGNlbGxwYWRkaW5nPSI1Ij4KICAgIDx0aGVhZD4KICAgICAgICA8dHIgc3R5bGU9ImJhY2tncm91bmQtY29sb3I6ICMwMGEyZTg7IGNvbG9yOiB3aGl0ZTsiPgogICAgICAgICAgICA8dGg+6I2v54mp5ZCN56ewPC90aD4KICAgICAgICAgICAgPHRoPumdtueCuTwvdGg+CiAgICAgICAgICAgIDx0aD7kvZznlKjmnLrliLY8L3RoPgogICAgICAgICAgICA8dGg+5Lit5Zu956CU5Y+R6LWb6YGT5o6S5ZCNPC90aD4KICAgICAgICAgICAgPHRoPuWFqOeQg+eglOWPkei1m+mBk+aOkuWQjTwvdGg+CiAgICAgICAgICAgIDx0aD7noJTlj5HmnLrmnoQ8L3RoPgogICAgICAgICAgICA8dGg+5YWo55CD5pyA6auY56CU5Y+R6Zi25q61PC90aD4KICAgICAgICAgICAgPHRoPuWFqOeQg+acgOmrmOeglOWPkemYtuauteW8gOWni+aXpeacnzwvdGg+CiAgICAgICAgICAgIDx0aD7kuK3lm73mnIDpq5jnoJTlj5HpmLbmrrU8L3RoPgogICAgICAgICAgICA8dGg+5Lit5Zu95pyA6auY56CU5Y+R6Zi25q615byA5aeL5pel5pyfPC90aD4KICAgICAgICA8L3RyPgogICAgPC90aGVhZD4KICAgIDx0Ym9keT4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD7ojrHovr7opb/otJ3mma48L3RkPgogICAgICAgICAgICA8dGQ+YWxidW1pbjtQQ1NLOTwvdGQ+CiAgICAgICAgICAgIDx0ZD5hbGJ1bWluw5dQQ1NLOeiejeWQiOibi+eZvTtQQ1NLOeaKkeWItuWJgjwvdGQ+CiAgICAgICAgICAgIDx0ZD4xLzE8L3RkPgogICAgICAgICAgICA8dGQ+MS8xPC90ZD4KICAgICAgICAgICAgPHRkPuS6kemhtuaWsOiAgDtMaWIgVGhlcmFwZXV0aWNzO+a1t+ajrueUn+eJqTwvdGQ+CiAgICAgICAgICAgIDx0ZD7mibnlh4bkuIrluII8L3RkPgogICAgICAgICAgICA8dGQ+MjAyNS0xMi0xMjwvdGQ+CiAgICAgICAgICAgIDx0ZD5JSUnmnJ/kuLTluoo8L3RkPgogICAgICAgICAgICA8dGQ+MjAyNC0wNi0yMTwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD7nkZ7ljaHopb/ljZXmipc8L3RkPgogICAgICAgICAgICA8dGQ+UENTSzk8L3RkPgogICAgICAgICAgICA8dGQ+YW50aS1QQ1NLOeWNleaKlzwvdGQ+CiAgICAgICAgICAgIDx0ZD42Lzk8L3RkPgogICAgICAgICAgICA8dGQ+Ni85PC90ZD4KICAgICAgICAgICAgPHRkPuaBkueRnuWMu+iNrzwvdGQ+CiAgICAgICAgICAgIDx0ZD7mibnlh4bkuIrluII8L3RkPgogICAgICAgICAgICA8dGQ+MjAyNS0wMS0wODwvdGQ+CiAgICAgICAgICAgIDx0ZD7mibnlh4bkuIrluII8L3RkPgogICAgICAgICAgICA8dGQ+MjAyNS0wMS0wODwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD7mmILmiIjnkZ7opb/ljZXmipc8L3RkPgogICAgICAgICAgICA8dGQ+UENTSzk8L3RkPgogICAgICAgICAgICA8dGQ+YW50aS1QQ1NLOeWNleaKlzwvdGQ+CiAgICAgICAgICAgIDx0ZD41Lzk8L3RkPgogICAgICAgICAgICA8dGQ+NS85PC90ZD4KICAgICAgICAgICAgPHRkPuWQm+WunueUn+eJqTvmpI3mgannlJ/niak8L3RkPgogICAgICAgICAgICA8dGQ+5om55YeG5LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjQtMTAtMDk8L3RkPgogICAgICAgICAgICA8dGQ+5om55YeG5LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjQtMTAtMDk8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+5LyK5Yqq6KW/5Y2V5oqXPC90ZD4KICAgICAgICAgICAgPHRkPlBDU0s5PC90ZD4KICAgICAgICAgICAgPHRkPmFudGktUENTSznljZXmipc8L3RkPgogICAgICAgICAgICA8dGQ+NC85PC90ZD4KICAgICAgICAgICAgPHRkPjQvOTwvdGQ+CiAgICAgICAgICAgIDx0ZD7lurfono3kuJzmlrk8L3RkPgogICAgICAgICAgICA8dGQ+5om55YeG5LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjQtMDktMjY8L3RkPgogICAgICAgICAgICA8dGQ+5om55YeG5LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjQtMDktMjY8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+5omY6I6x6KW/5Y2V5oqXPC90ZD4KICAgICAgICAgICAgPHRkPlBDU0s5PC90ZD4KICAgICAgICAgICAgPHRkPmFudGktUENTSznljZXmipc8L3RkPgogICAgICAgICAgICA8dGQ+My85PC90ZD4KICAgICAgICAgICAgPHRkPjMvOTwvdGQ+CiAgICAgICAgICAgIDx0ZD7kv6Hovr7nlJ/niak7QWRpbWFiPC90ZD4KICAgICAgICAgICAgPHRkPuaJueWHhuS4iuW4gjwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDIzLTA4LTE1PC90ZD4KICAgICAgICAgICAgPHRkPuaJueWHhuS4iuW4gjwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDIzLTA4LTE1PC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPuiLseWFi+WPuOWFsDwvdGQ+CiAgICAgICAgICAgIDx0ZD5QQ1NLOTwvdGQ+CiAgICAgICAgICAgIDx0ZD5zaVJOQeeWl+azlTwvdGQ+CiAgICAgICAgICAgIDx0ZD4xLzI3PC90ZD4KICAgICAgICAgICAgPHRkPjEvMjc8L3RkPgogICAgICAgICAgICA8dGQ+VGhlIE1lZGljaW5lcyBDb21wYW55O0FsbnlsYW0gUGhhcm1hY2V1dGljYWxzPC90ZD4KICAgICAgICAgICAgPHRkPuaJueWHhuS4iuW4gjwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDIwLTEyLTA5PC90ZD4KICAgICAgICAgICAgPHRkPuaJueWHhuS4iuW4gjwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDIzLTA4LTIyPC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPumYv+WIqeilv+WwpOWNleaKlzwvdGQ+CiAgICAgICAgICAgIDx0ZD5QQ1NLOTwvdGQ+CiAgICAgICAgICAgIDx0ZD5hbnRpLVBDU0s55Y2V5oqXPC90ZD4KICAgICAgICAgICAgPHRkPjIvOTwvdGQ+CiAgICAgICAgICAgIDx0ZD4yLzk8L3RkPgogICAgICAgICAgICA8dGQ+U2Fub2ZpO1JlZ2VuZXJvbiBQaGFybWFjZXV0aWNhbHM8L3RkPgogICAgICAgICAgICA8dGQ+5om55YeG5LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMTUtMDctMjQ8L3RkPgogICAgICAgICAgICA8dGQ+5om55YeG5LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMTktMTItMjY8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+5L6d5rSb5bCk5Y2V5oqXPC90ZD4KICAgICAgICAgICAgPHRkPlBDU0s5PC90ZD4KICAgICAgICAgICAgPHRkPmFudGktUENTSznljZXmipc8L3RkPgogICAgICAgICAgICA8dGQ+MS85PC90ZD4KICAgICAgICAgICAgPHRkPjEvOTwvdGQ+CiAgICAgICAgICAgIDx0ZD5BbWdlbjtBc3RlbGxhcyBQaGFybWE8L3RkPgogICAgICAgICAgICA8dGQ+5om55YeG5LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMTUtMDctMTc8L3RkPgogICAgICAgICAgICA8dGQ+5om55YeG5LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMTgtMDctMTA8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+5rOw5Y2h6KW/5Y2V5oqXPC90ZD4KICAgICAgICAgICAgPHRkPlBDU0s5PC90ZD4KICAgICAgICAgICAgPHRkPmFudGktUENTSznljZXmipc8L3RkPgogICAgICAgICAgICA8dGQ+Ny85PC90ZD4KICAgICAgICAgICAgPHRkPjcvOTwvdGQ+CiAgICAgICAgICAgIDx0ZD7kv6Hnq4vms7A8L3RkPgogICAgICAgICAgICA8dGQ+55Sz6K+35LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjUtMDktMTk8L3RkPgogICAgICAgICAgICA8dGQ+55Sz6K+35LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjUtMDktMTk8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+U1IwNDM8L3RkPgogICAgICAgICAgICA8dGQ+UENTSzk8L3RkPgogICAgICAgICAgICA8dGQ+c2lSTkHnlpfms5U8L3RkPgogICAgICAgICAgICA8dGQ+My8yNzwvdGQ+CiAgICAgICAgICAgIDx0ZD4zLzI3PC90ZD4KICAgICAgICAgICAgPHRkPum9kOmygeWItuiNrzvnkZ7ljZrnlJ/niak8L3RkPgogICAgICAgICAgICA8dGQ+SUlJ5pyf5Li05bqKPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjYtMDItMjc8L3RkPgogICAgICAgICAgICA8dGQ+SUnmnJ/kuLTluoo8L3RkPgogICAgICAgICAgICA8dGQ+MjAyNC0xMi0xOTwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD5TWUgyMDUzPC90ZD4KICAgICAgICAgICAgPHRkPlBDU0s5PC90ZD4KICAgICAgICAgICAgPHRkPnNpUk5B55aX5rOVPC90ZD4KICAgICAgICAgICAgPHRkPjIvMjc8L3RkPgogICAgICAgICAgICA8dGQ+Mi8yNzwvdGQ+CiAgICAgICAgICAgIDx0ZD7nn7Poja/pm4blm6I8L3RkPgogICAgICAgICAgICA8dGQ+SUlJ5pyf5Li05bqKPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjUtMTItMTU8L3RkPgogICAgICAgICAgICA8dGQ+SUlJ5pyf5Li05bqKPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjUtMTItMTU8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+bGFyb3Byb3ZzdGF0PC90ZD4KICAgICAgICAgICAgPHRkPlBDU0s5PC90ZD4KICAgICAgICAgICAgPHRkPlBDU0s55oqR5Yi25YmCPC90ZD4KICAgICAgICAgICAgPHRkPjIvMTc8L3RkPgogICAgICAgICAgICA8dGQ+Mi8xNzwvdGQ+CiAgICAgICAgICAgIDx0ZD5Bc3RyYVplbmVjYTtEb2dtYSBUaGVyYXBldXRpY3M8L3RkPgogICAgICAgICAgICA8dGQ+SUlJ5pyf5Li05bqKPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjUtMDYtMDI8L3RkPgogICAgICAgICAgICA8dGQ+SUlJ5pyf5Li05bqKPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjUtMDYtMDI8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+ZW5saWNpdGlkZTwvdGQ+CiAgICAgICAgICAgIDx0ZD5QQ1NLOTwvdGQ+CiAgICAgICAgICAgIDx0ZD5QQ1NLOeaKkeWItuWJgjwvdGQ+CiAgICAgICAgICAgIDx0ZD4xLzE3PC90ZD4KICAgICAgICAgICAgPHRkPjEvMTc8L3RkPgogICAgICAgICAgICA8dGQ+TWVyY2sgJiBDby48L3RkPgogICAgICAgICAgICA8dGQ+SUlJ5pyf5Li05bqKPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjMtMDctMTk8L3RkPgogICAgICAgICAgICA8dGQ+SUlJ5pyf5Li05bqKPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjMtMDctMTk8L3RkPgogICAgICAgIDwvdHI+CiAgICA8L3Rib2R5Pgo8L3RhYmxlPgoKPHA+6LWE5paZ5p2l5rqQ77ya5Yy76I2v6a2U5pa577yI5oiq5q2iMjAyNi8wNC8yMe+8ie+8jOWbveazsOa1t+mAmuivgeWIuOeglOeptjwvcD4=
收藏
竞争格局
2026-05-28
原图定位
查看详情
CDK4/6i耐药HR+乳腺癌III期阶段以后在研品种(最高研发阶段开始日期在2023年及以后)
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
收藏
行业数据
2026-05-11
原图定位
查看详情
各线食管鳞癌的在研创新药格局梳理(III期及申请上市阶段)
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
收藏
竞争格局
2026-05-11
原图定位
查看详情
PD(L)1*VEGF双抗针对一线CRC全球III期临床情况
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
收藏
行业数据
2026-03-13
原图定位
查看详情
2024年东盟互联互通能力及2040年AIMS III可再生能源目标情况
IyMjIOaVsOaNruihqOagvAoKfCDlubTku70gICB8IOexu+WIqyAgICAgICAgICAgICAgIHwg5a656YeP77yITVfvvIkgfAp8LS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tfAp8IDIwMjQgICB8IOeOsOacieeahCAgICAgICAgICAgICB8IOe6pjI1MDAgICAgIHwKfCAyMDI0ICAgfCDmraPlnKjlu7rorr7kuK0gICAgICAgICB8IOe6pjUwMCAgICAgIHwKfCAyMDQwICAgfCBBSU1TIElJSeaWsOmhueebriAgICAgfCDnuqYyODUwMCAgICB8CgoKIyMjIOi1hOaWmeadpea6kCAgCuS4nOebn+iDvea6kOS4reW/g++8iDIwMjTvvInvvIzkuJznm5/nlLXnvZHkupLogZTpobnnm67mpoLlhrXjgII=
收藏
行业数据
2026-03-11
原图定位
查看详情
从 AIMS III 第 1-2 阶段和国家电力部门规划中选定的主要跨境互联项目
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
收藏
行业数据
2026-03-11
原图定位
查看详情
ASEAN interconnector capacity in 2024 and in the AIMS III Renewable Energy Target Scenario for 2040
fCDnsbvliKsgICAgICAgICAgICAgICB8IDIwMjQgICAgICAgfCAyMDQwICAgICAgICAgfAp8LS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tfAp8IOeOsOaciSAoRXhpc3RpbmcpICAgIHwgMzAwMCBNVyAgICB8IOKAlCAgICAgICAgICAgIHwKfCDlnKjlu7ogKFVuZGVyIGNvbnN0cnVjdGlvbikgfCAwIE1XICAgICAgIHwg4oCUICAgICAgICAgICAgfAp8IEFJTVMgSUlJ5paw6aG555uuICAgICAgfCDigJQgICAgICAgICAgfCAyODUwMCBNVyAgICAgfAoK6LWE5paZ5p2l5rqQ77yaQVNFQU4gQ2VudHJlIGZvciBFbmVyZ3kgKDIwMjQpLCBBU0VBTiBQb3dlciBHcmlkIEludGVyY29ubmVjdGlvbnMgUHJvamVjdCBQcm9maWxlcy4=
收藏
行业数据
2026-03-11
原图定位
查看详情
Figure 2. Digital Economy Phase III (Highly Developed) Overall Digital Readiness Index Scores = 80-100
fCDlm73lrrYgICAgICAgICB8IOaVsOWtl+WHhuWkh+aMh+aVsOW+l+WIhuiMg+WbtCB8CnwtLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8IFN3ZWRlbiAgICAgICB8IDgwIC0gMTAwICAgICAgICAgICAgIHwKfCBEZW5tYXJrICAgICAgfCA4MCAtIDEwMCAgICAgICAgICAgICB8CnwgTm9yd2F5ICAgICAgIHwgODAgLSAxMDAgICAgICAgICAgICAgfAp8IEZpbmxhbmQgICAgICB8IDgwIC0gMTAwICAgICAgICAgICAgIHwKfCBTd2l0emVybGFuZCAgfCA4MCAtIDEwMCAgICAgICAgICAgICB8CnwgSWNlbGFuZCAgICAgIHwgODAgLSAxMDAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5omA5o+Q5L6b5Zu+54mH
收藏
行业数据
2026-03-11
原图定位
查看详情
Companies under Target Segment III (Key Chemical Synthesis Based KSMs/Drug Intermediates) are as follows:
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
收藏
行业数据
2026-03-11
原图定位
查看详情
Individual player performance (III/IV)-Standalone
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
收藏
行业数据
2026-03-04
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
替妥尤单抗在 III 期临床研究(RESTORE-1 研究)中展示了显著的治疗效果。研究共纳入 82 例患者,按照 2:1 随机分配到替妥尤单抗组和安慰剂组,治疗时间为 24 周。主要研究结果包括:1):眼球突出应答率:第 24 周时,替妥尤单抗组的眼球突出应答率为 85.8%,显著高于安慰剂组的 3.8%。2):眼球突出度变化:替妥尤单抗组眼球突出度较基线回落了2.85mm,而安慰剂组则几乎没有变化。3)复视的变化:替妥尤单抗组在治疗 24 周后复视显著改善。4)甲状腺眼病临床活动评分(CAS):第 24周时,替妥尤单抗组研究眼的 CAS值达到 0或 1分的受试者百分比为 83.5%,显著高于安慰剂组的 16.6%。5)眼球总应答率:替妥尤单抗组研究眼的眼球总应答率为 80.2%,而安慰剂组仅为 3.6%。整体看,替妥尤单抗能够显著改善甲状腺眼病患者的眼球突出度、疾病活动程度和生活质量,且在整个研究治疗期间,整体安全性良好。
行业数据
原图定位
当前图表所属:
信达生物-港股公司深度报告:IO+ADC 全球创新领先减重等慢病开花-250427(30页).pdf
IL-23靶点药物国内竞争格局(I期及以上)
玛仕度肽、司美格鲁肽及替尔泊肽不同剂量下减重数据对比(非头对头)
玛仕度肽共有7项III期注册研究进行中
CLDN18.2/CD3双靶点药物研发格局(申报临床及以上)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》